BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lu LH, Wei W, Li SH, Zhang YF, Guo RP. The lymphocyte-C-reactive protein ratio as the optimal inflammation-based score in patients with hepatocellular carcinoma underwent TACE. Aging (Albany NY) 2021;13:5358-68. [PMID: 33589570 DOI: 10.18632/aging.202468] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Young S, Sanghvi T, Sharma S, Richardson C, Rubin N, Richards M, D'Souza D, Flanagan S, Golzarian J. Local recurrence following complete radiologic response in patients treated with transarterial chemoembolization for hepatocellular carcinoma. Diagn Interv Imaging 2022:S2211-5684(22)00006-7. [PMID: 35115276 DOI: 10.1016/j.diii.2022.01.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
2 Zhang Z, Chen Z. Higher Systemic Immune-Inflammation Index is associated with higher likelihood of peripheral arterial disease. Ann Vasc Surg 2021:S0890-5096(21)00966-3. [PMID: 34954036 DOI: 10.1016/j.avsg.2021.12.011] [Reference Citation Analysis]
3 Young S, Cam I, Gencturk M, Rubin N, D'souza D, Flanagan S, Golzarian J, Sanghvi T. Inflammatory Scores: Comparison and Utility in HCC Patients Undergoing Transarterial Chemoembolization in a North American Cohort. J Hepatocell Carcinoma 2021;8:1513-24. [PMID: 34881208 DOI: 10.2147/JHC.S335183] [Reference Citation Analysis]
4 Ren L, Chen D, Xu W, Xu T, Wei R, Suo L, Huang Y, Chen H, Liao W. Predictive potential of Nomogram based on GMWG for patients with hepatocellular carcinoma after radical resection. BMC Cancer 2021;21:817. [PMID: 34266388 DOI: 10.1186/s12885-021-08565-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]